Edwards Lifesciences Corporation (EW) Shareholders’ equity 2016–2025
Edwards Lifesciences Corporation (EW) shareholders’ equity at each fiscal year-end, per SEC filings.
$10.3BFY2025 · since FY2016: $2.6B → $10.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.3B | +3.4% |
| FY2024 | $10.0B | +50.4% |
| FY2023 | $6.7B | +14.5% |
| FY2022 | $5.8B | -0.5% |
| FY2021 | $5.8B | +27.6% |
| FY2020 | $4.6B | +10.3% |
| FY2019 | $4.1B | +32.1% |
| FY2018 | $3.1B | +6.2% |
| FY2017 | $3.0B | +12.9% |
| FY2016 | $2.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice